Global Nucleic Acid Blood Screening Market Growth 2024-2030

Product Code: 1162489

Industry: Medical Devices & Consumables

Published: Feb 07,2024

Pages: 133

Delivery Time: 2-3 business days

Global Nucleic Acid Blood Screening Market Growth 2024-2030

Product Code: 1162489

Industry: Medical Devices & Consumables

Published: Feb 07,2024

Pages: 133

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

Blood screening, also known as blood source screening, refers to the screening of blood donors and plasma apheresis groups in order to ensure the safety of clinical blood and the quality of blood products, and to prevent blood-borne pathogen-positive plasma from being directly imported into patients or used in the production of blood products. Screening performed.

The global Nucleic Acid Blood Screening market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Nucleic Acid Blood Screening Industry Forecast” looks at past sales and reviews total world Nucleic Acid Blood Screening sales in 2023, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Blood Screening sales for 2024 through 2030. With Nucleic Acid Blood Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Blood Screening industry.

This Insight Report provides a comprehensive analysis of the global Nucleic Acid Blood Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Blood Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Blood Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Blood Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Blood Screening.

United States market for Nucleic Acid Blood Screening is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Nucleic Acid Blood Screening is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Nucleic Acid Blood Screening is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Nucleic Acid Blood Screening players cover Roche, Grifols Diagnostic Solutions, PerkinElmer, KHB and Bacme Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Blood Screening market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
    Blood Screening Equipment
    blood Screening Reagents

Segmentation by application
    Blood Center
    Central Blood Station
    Central Blood Bank

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Roche
    Grifols Diagnostic Solutions
    PerkinElmer
    KHB
    Bacme Bio
    Daan Gene
    Wantai Biotechnology
    Sansure Biotech
    Zhuhai Livzon Reagents
    Bio-Rad Laboratories
    Horiba
    Thermo Fisher Scientific
    bioMerieux
    Danaher
    Abbott
    BD
    Mindray

Key Questions Addressed in this Report
What is the 10-year outlook for the global Nucleic Acid Blood Screening market?
What factors are driving Nucleic Acid Blood Screening market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nucleic Acid Blood Screening market opportunities vary by end market size?
How does Nucleic Acid Blood Screening break out type, application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Nucleic Acid Blood Screening Annual Sales 2019-2030
        2.1.2 World Current & Future Analysis for Nucleic Acid Blood Screening by Geographic Region, 2019, 2023 & 2030
        2.1.3 World Current & Future Analysis for Nucleic Acid Blood Screening by Country/Region, 2019, 2023 & 2030
    2.2 Nucleic Acid Blood Screening Segment by Type
        2.2.1 Blood Screening Equipment
        2.2.2 blood Screening Reagents
    2.3 Nucleic Acid Blood Screening Sales by Type
        2.3.1 Global Nucleic Acid Blood Screening Sales Market Share by Type (2019-2024)
        2.3.2 Global Nucleic Acid Blood Screening Revenue and Market Share by Type (2019-2024)
        2.3.3 Global Nucleic Acid Blood Screening Sale Price by Type (2019-2024)
    2.4 Nucleic Acid Blood Screening Segment by Application
        2.4.1 Blood Center
        2.4.2 Central Blood Station
        2.4.3 Central Blood Bank
    2.5 Nucleic Acid Blood Screening Sales by Application
        2.5.1 Global Nucleic Acid Blood Screening Sale Market Share by Application (2019-2024)
        2.5.2 Global Nucleic Acid Blood Screening Revenue and Market Share by Application (2019-2024)
        2.5.3 Global Nucleic Acid Blood Screening Sale Price by Application (2019-2024)

3 Global Nucleic Acid Blood Screening by Company
    3.1 Global Nucleic Acid Blood Screening Breakdown Data by Company
        3.1.1 Global Nucleic Acid Blood Screening Annual Sales by Company (2019-2024)
        3.1.2 Global Nucleic Acid Blood Screening Sales Market Share by Company (2019-2024)
    3.2 Global Nucleic Acid Blood Screening Annual Revenue by Company (2019-2024)
        3.2.1 Global Nucleic Acid Blood Screening Revenue by Company (2019-2024)
        3.2.2 Global Nucleic Acid Blood Screening Revenue Market Share by Company (2019-2024)
    3.3 Global Nucleic Acid Blood Screening Sale Price by Company
    3.4 Key Manufacturers Nucleic Acid Blood Screening Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Nucleic Acid Blood Screening Product Location Distribution
        3.4.2 Players Nucleic Acid Blood Screening Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Nucleic Acid Blood Screening by Geographic Region
    4.1 World Historic Nucleic Acid Blood Screening Market Size by Geographic Region (2019-2024)
        4.1.1 Global Nucleic Acid Blood Screening Annual Sales by Geographic Region (2019-2024)
        4.1.2 Global Nucleic Acid Blood Screening Annual Revenue by Geographic Region (2019-2024)
    4.2 World Historic Nucleic Acid Blood Screening Market Size by Country/Region (2019-2024)
        4.2.1 Global Nucleic Acid Blood Screening Annual Sales by Country/Region (2019-2024)
        4.2.2 Global Nucleic Acid Blood Screening Annual Revenue by Country/Region (2019-2024)
    4.3 Americas Nucleic Acid Blood Screening Sales Growth
    4.4 APAC Nucleic Acid Blood Screening Sales Growth
    4.5 Europe Nucleic Acid Blood Screening Sales Growth
    4.6 Middle East & Africa Nucleic Acid Blood Screening Sales Growth

5 Americas
    5.1 Americas Nucleic Acid Blood Screening Sales by Country
        5.1.1 Americas Nucleic Acid Blood Screening Sales by Country (2019-2024)
        5.1.2 Americas Nucleic Acid Blood Screening Revenue by Country (2019-2024)
    5.2 Americas Nucleic Acid Blood Screening Sales by Type
    5.3 Americas Nucleic Acid Blood Screening Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Nucleic Acid Blood Screening Sales by Region
        6.1.1 APAC Nucleic Acid Blood Screening Sales by Region (2019-2024)
        6.1.2 APAC Nucleic Acid Blood Screening Revenue by Region (2019-2024)
    6.2 APAC Nucleic Acid Blood Screening Sales by Type
    6.3 APAC Nucleic Acid Blood Screening Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Nucleic Acid Blood Screening by Country
        7.1.1 Europe Nucleic Acid Blood Screening Sales by Country (2019-2024)
        7.1.2 Europe Nucleic Acid Blood Screening Revenue by Country (2019-2024)
    7.2 Europe Nucleic Acid Blood Screening Sales by Type
    7.3 Europe Nucleic Acid Blood Screening Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Nucleic Acid Blood Screening by Country
        8.1.1 Middle East & Africa Nucleic Acid Blood Screening Sales by Country (2019-2024)
        8.1.2 Middle East & Africa Nucleic Acid Blood Screening Revenue by Country (2019-2024)
    8.2 Middle East & Africa Nucleic Acid Blood Screening Sales by Type
    8.3 Middle East & Africa Nucleic Acid Blood Screening Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Nucleic Acid Blood Screening
    10.3 Manufacturing Process Analysis of Nucleic Acid Blood Screening
    10.4 Industry Chain Structure of Nucleic Acid Blood Screening

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Nucleic Acid Blood Screening Distributors
    11.3 Nucleic Acid Blood Screening Customer

12 World Forecast Review for Nucleic Acid Blood Screening by Geographic Region
    12.1 Global Nucleic Acid Blood Screening Market Size Forecast by Region
        12.1.1 Global Nucleic Acid Blood Screening Forecast by Region (2025-2030)
        12.1.2 Global Nucleic Acid Blood Screening Annual Revenue Forecast by Region (2025-2030)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Nucleic Acid Blood Screening Forecast by Type
    12.7 Global Nucleic Acid Blood Screening Forecast by Application

13 Key Players Analysis
    13.1 Roche
        13.1.1 Roche Company Information
        13.1.2 Roche Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.1.3 Roche Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.1.4 Roche Main Business Overview
        13.1.5 Roche Latest Developments
    13.2 Grifols Diagnostic Solutions
        13.2.1 Grifols Diagnostic Solutions Company Information
        13.2.2 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.2.3 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.2.4 Grifols Diagnostic Solutions Main Business Overview
        13.2.5 Grifols Diagnostic Solutions Latest Developments
    13.3 PerkinElmer
        13.3.1 PerkinElmer Company Information
        13.3.2 PerkinElmer Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.3.3 PerkinElmer Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.3.4 PerkinElmer Main Business Overview
        13.3.5 PerkinElmer Latest Developments
    13.4 KHB
        13.4.1 KHB Company Information
        13.4.2 KHB Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.4.3 KHB Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.4.4 KHB Main Business Overview
        13.4.5 KHB Latest Developments
    13.5 Bacme Bio
        13.5.1 Bacme Bio Company Information
        13.5.2 Bacme Bio Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.5.3 Bacme Bio Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.5.4 Bacme Bio Main Business Overview
        13.5.5 Bacme Bio Latest Developments
    13.6 Daan Gene
        13.6.1 Daan Gene Company Information
        13.6.2 Daan Gene Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.6.3 Daan Gene Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.6.4 Daan Gene Main Business Overview
        13.6.5 Daan Gene Latest Developments
    13.7 Wantai Biotechnology
        13.7.1 Wantai Biotechnology Company Information
        13.7.2 Wantai Biotechnology Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.7.3 Wantai Biotechnology Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.7.4 Wantai Biotechnology Main Business Overview
        13.7.5 Wantai Biotechnology Latest Developments
    13.8 Sansure Biotech
        13.8.1 Sansure Biotech Company Information
        13.8.2 Sansure Biotech Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.8.3 Sansure Biotech Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.8.4 Sansure Biotech Main Business Overview
        13.8.5 Sansure Biotech Latest Developments
    13.9 Zhuhai Livzon Reagents
        13.9.1 Zhuhai Livzon Reagents Company Information
        13.9.2 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.9.3 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.9.4 Zhuhai Livzon Reagents Main Business Overview
        13.9.5 Zhuhai Livzon Reagents Latest Developments
    13.10 Bio-Rad Laboratories
        13.10.1 Bio-Rad Laboratories Company Information
        13.10.2 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.10.3 Bio-Rad Laboratories Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.10.4 Bio-Rad Laboratories Main Business Overview
        13.10.5 Bio-Rad Laboratories Latest Developments
    13.11 Horiba
        13.11.1 Horiba Company Information
        13.11.2 Horiba Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.11.3 Horiba Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.11.4 Horiba Main Business Overview
        13.11.5 Horiba Latest Developments
    13.12 Thermo Fisher Scientific
        13.12.1 Thermo Fisher Scientific Company Information
        13.12.2 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.12.3 Thermo Fisher Scientific Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.12.4 Thermo Fisher Scientific Main Business Overview
        13.12.5 Thermo Fisher Scientific Latest Developments
    13.13 bioMerieux
        13.13.1 bioMerieux Company Information
        13.13.2 bioMerieux Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.13.3 bioMerieux Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.13.4 bioMerieux Main Business Overview
        13.13.5 bioMerieux Latest Developments
    13.14 Danaher
        13.14.1 Danaher Company Information
        13.14.2 Danaher Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.14.3 Danaher Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.14.4 Danaher Main Business Overview
        13.14.5 Danaher Latest Developments
    13.15 Abbott
        13.15.1 Abbott Company Information
        13.15.2 Abbott Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.15.3 Abbott Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.15.4 Abbott Main Business Overview
        13.15.5 Abbott Latest Developments
    13.16 BD
        13.16.1 BD Company Information
        13.16.2 BD Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.16.3 BD Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.16.4 BD Main Business Overview
        13.16.5 BD Latest Developments
    13.17 Mindray
        13.17.1 Mindray Company Information
        13.17.2 Mindray Nucleic Acid Blood Screening Product Portfolios and Specifications
        13.17.3 Mindray Nucleic Acid Blood Screening Sales, Revenue, Price and Gross Margin (2019-2024)
        13.17.4 Mindray Main Business Overview
        13.17.5 Mindray Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
    Table 1. Nucleic Acid Blood Screening Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
    Table 2. Nucleic Acid Blood Screening Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
    Table 3. Major Players of Blood Screening Equipment
    Table 4. Major Players of blood Screening Reagents
    Table 5. Global Nucleic Acid Blood Screening Sales by Type (2019-2024) & (K Units)
    Table 6. Global Nucleic Acid Blood Screening Sales Market Share by Type (2019-2024)
    Table 7. Global Nucleic Acid Blood Screening Revenue by Type (2019-2024) & ($ million)
    Table 8. Global Nucleic Acid Blood Screening Revenue Market Share by Type (2019-2024)
    Table 9. Global Nucleic Acid Blood Screening Sale Price by Type (2019-2024) & (US$/Unit)
    Table 10. Global Nucleic Acid Blood Screening Sales by Application (2019-2024) & (K Units)
    Table 11. Global Nucleic Acid Blood Screening Sales Market Share by Application (2019-2024)
    Table 12. Global Nucleic Acid Blood Screening Revenue by Application (2019-2024)
    Table 13. Global Nucleic Acid Blood Screening Revenue Market Share by Application (2019-2024)
    Table 14. Global Nucleic Acid Blood Screening Sale Price by Application (2019-2024) & (US$/Unit)
    Table 15. Global Nucleic Acid Blood Screening Sales by Company (2019-2024) & (K Units)
    Table 16. Global Nucleic Acid Blood Screening Sales Market Share by Company (2019-2024)
    Table 17. Global Nucleic Acid Blood Screening Revenue by Company (2019-2024) ($ Millions)
    Table 18. Global Nucleic Acid Blood Screening Revenue Market Share by Company (2019-2024)
    Table 19. Global Nucleic Acid Blood Screening Sale Price by Company (2019-2024) & (US$/Unit)
    Table 20. Key Manufacturers Nucleic Acid Blood Screening Producing Area Distribution and Sales Area
    Table 21. Players Nucleic Acid Blood Screening Products Offered
    Table 22. Nucleic Acid Blood Screening Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Nucleic Acid Blood Screening Sales by Geographic Region (2019-2024) & (K Units)
    Table 26. Global Nucleic Acid Blood Screening Sales Market Share Geographic Region (2019-2024)
    Table 27. Global Nucleic Acid Blood Screening Revenue by Geographic Region (2019-2024) & ($ millions)
    Table 28. Global Nucleic Acid Blood Screening Revenue Market Share by Geographic Region (2019-2024)
    Table 29. Global Nucleic Acid Blood Screening Sales by Country/Region (2019-2024) & (K Units)
    Table 30. Global Nucleic Acid Blood Screening Sales Market Share by Country/Region (2019-2024)
    Table 31. Global Nucleic Acid Blood Screening Revenue by Country/Region (2019-2024) & ($ millions)
    Table 32. Global Nucleic Acid Blood Screening Revenue Market Share by Country/Region (2019-2024)
    Table 33. Americas Nucleic Acid Blood Screening Sales by Country (2019-2024) & (K Units)
    Table 34. Americas Nucleic Acid Blood Screening Sales Market Share by Country (2019-2024)
    Table 35. Americas Nucleic Acid Blood Screening Revenue by Country (2019-2024) & ($ Millions)
    Table 36. Americas Nucleic Acid Blood Screening Revenue Market Share by Country (2019-2024)
    Table 37. Americas Nucleic Acid Blood Screening Sales by Type (2019-2024) & (K Units)
    Table 38. Americas Nucleic Acid Blood Screening Sales by Application (2019-2024) & (K Units)
    Table 39. APAC Nucleic Acid Blood Screening Sales by Region (2019-2024) & (K Units)
    Table 40. APAC Nucleic Acid Blood Screening Sales Market Share by Region (2019-2024)
    Table 41. APAC Nucleic Acid Blood Screening Revenue by Region (2019-2024) & ($ Millions)
    Table 42. APAC Nucleic Acid Blood Screening Revenue Market Share by Region (2019-2024)
    Table 43. APAC Nucleic Acid Blood Screening Sales by Type (2019-2024) & (K Units)
    Table 44. APAC Nucleic Acid Blood Screening Sales by Application (2019-2024) & (K Units)
    Table 45. Europe Nucleic Acid Blood Screening Sales by Country (2019-2024) & (K Units)
    Table 46. Europe Nucleic Acid Blood Screening Sales Market Share by Country (2019-2024)
    Table 47. Europe Nucleic Acid Blood Screening Revenue by Country (2019-2024) & ($ Millions)
    Table 48. Europe Nucleic Acid Blood Screening Revenue Market Share by Country (2019-2024)
    Table 49. Europe Nucleic Acid Blood Screening Sales by Type (2019-2024) & (K Units)
    Table 50. Europe Nucleic Acid Blood Screening Sales by Application (2019-2024) & (K Units)
    Table 51. Middle East & Africa Nucleic Acid Blood Screening Sales by Country (2019-2024) & (K Units)
    Table 52. Middle East & Africa Nucleic Acid Blood Screening Sales Market Share by Country (2019-2024)
    Table 53. Middle East & Africa Nucleic Acid Blood Screening Revenue by Country (2019-2024) & ($ Millions)
    Table 54. Middle East & Africa Nucleic Acid Blood Screening Revenue Market Share by Country (2019-2024)
    Table 55. Middle East & Africa Nucleic Acid Blood Screening Sales by Type (2019-2024) & (K Units)
    Table 56. Middle East & Africa Nucleic Acid Blood Screening Sales by Application (2019-2024) & (K Units)
    Table 57. Key Market Drivers & Growth Opportunities of Nucleic Acid Blood Screening
    Table 58. Key Market Challenges & Risks of Nucleic Acid Blood Screening
    Table 59. Key Industry Trends of Nucleic Acid Blood Screening
    Table 60. Nucleic Acid Blood Screening Raw Material
    Table 61. Key Suppliers of Raw Materials
    Table 62. Nucleic Acid Blood Screening Distributors List
    Table 63. Nucleic Acid Blood Screening Customer List
    Table 64. Global Nucleic Acid Blood Screening Sales Forecast by Region (2025-2030) & (K Units)
    Table 65. Global Nucleic Acid Blood Screening Revenue Forecast by Region (2025-2030) & ($ millions)
    Table 66. Americas Nucleic Acid Blood Screening Sales Forecast by Country (2025-2030) & (K Units)
    Table 67. Americas Nucleic Acid Blood Screening Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 68. APAC Nucleic Acid Blood Screening Sales Forecast by Region (2025-2030) & (K Units)
    Table 69. APAC Nucleic Acid Blood Screening Revenue Forecast by Region (2025-2030) & ($ millions)
    Table 70. Europe Nucleic Acid Blood Screening Sales Forecast by Country (2025-2030) & (K Units)
    Table 71. Europe Nucleic Acid Blood Screening Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 72. Middle East & Africa Nucleic Acid Blood Screening Sales Forecast by Country (2025-2030) & (K Units)
    Table 73. Middle East & Africa Nucleic Acid Blood Screening Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 74. Global Nucleic Acid Blood Screening Sales Forecast by Type (2025-2030) & (K Units)
    Table 75. Global Nucleic Acid Blood Screening Revenue Forecast by Type (2025-2030) & ($ Millions)
    Table 76. Global Nucleic Acid Blood Screening Sales Forecast by Application (2025-2030) & (K Units)
    Table 77. Global Nucleic Acid Blood Screening Revenue Forecast by Application (2025-2030) & ($ Millions)
    Table 78. Roche Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 79. Roche Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 80. Roche Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 81. Roche Main Business
    Table 82. Roche Latest Developments
    Table 83. Grifols Diagnostic Solutions Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 84. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 85. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 86. Grifols Diagnostic Solutions Main Business
    Table 87. Grifols Diagnostic Solutions Latest Developments
    Table 88. PerkinElmer Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 89. PerkinElmer Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 90. PerkinElmer Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 91. PerkinElmer Main Business
    Table 92. PerkinElmer Latest Developments
    Table 93. KHB Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 94. KHB Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 95. KHB Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 96. KHB Main Business
    Table 97. KHB Latest Developments
    Table 98. Bacme Bio Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 99. Bacme Bio Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 100. Bacme Bio Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 101. Bacme Bio Main Business
    Table 102. Bacme Bio Latest Developments
    Table 103. Daan Gene Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 104. Daan Gene Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 105. Daan Gene Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 106. Daan Gene Main Business
    Table 107. Daan Gene Latest Developments
    Table 108. Wantai Biotechnology Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 109. Wantai Biotechnology Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 110. Wantai Biotechnology Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 111. Wantai Biotechnology Main Business
    Table 112. Wantai Biotechnology Latest Developments
    Table 113. Sansure Biotech Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 114. Sansure Biotech Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 115. Sansure Biotech Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 116. Sansure Biotech Main Business
    Table 117. Sansure Biotech Latest Developments
    Table 118. Zhuhai Livzon Reagents Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 119. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 120. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 121. Zhuhai Livzon Reagents Main Business
    Table 122. Zhuhai Livzon Reagents Latest Developments
    Table 123. Bio-Rad Laboratories Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 124. Bio-Rad Laboratories Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 125. Bio-Rad Laboratories Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 126. Bio-Rad Laboratories Main Business
    Table 127. Bio-Rad Laboratories Latest Developments
    Table 128. Horiba Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 129. Horiba Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 130. Horiba Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 131. Horiba Main Business
    Table 132. Horiba Latest Developments
    Table 133. Thermo Fisher Scientific Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 134. Thermo Fisher Scientific Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 135. Thermo Fisher Scientific Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 136. Thermo Fisher Scientific Main Business
    Table 137. Thermo Fisher Scientific Latest Developments
    Table 138. bioMerieux Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 139. bioMerieux Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 140. bioMerieux Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 141. bioMerieux Main Business
    Table 142. bioMerieux Latest Developments
    Table 143. Danaher Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 144. Danaher Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 145. Danaher Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 146. Danaher Main Business
    Table 147. Danaher Latest Developments
    Table 148. Abbott Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 149. Abbott Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 150. Abbott Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 151. Abbott Main Business
    Table 152. Abbott Latest Developments
    Table 153. BD Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 154. BD Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 155. BD Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 156. BD Main Business
    Table 157. BD Latest Developments
    Table 158. Mindray Basic Information, Nucleic Acid Blood Screening Manufacturing Base, Sales Area and Its Competitors
    Table 159. Mindray Nucleic Acid Blood Screening Product Portfolios and Specifications
    Table 160. Mindray Nucleic Acid Blood Screening Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 161. Mindray Main Business
    Table 162. Mindray Latest Developments
List of Figures
    Figure 1. Picture of Nucleic Acid Blood Screening
    Figure 2. Nucleic Acid Blood Screening Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Nucleic Acid Blood Screening Sales Growth Rate 2019-2030 (K Units)
    Figure 7. Global Nucleic Acid Blood Screening Revenue Growth Rate 2019-2030 ($ Millions)
    Figure 8. Nucleic Acid Blood Screening Sales by Region (2019, 2023 & 2030) & ($ Millions)
    Figure 9. Product Picture of Blood Screening Equipment
    Figure 10. Product Picture of blood Screening Reagents
    Figure 11. Global Nucleic Acid Blood Screening Sales Market Share by Type in 2023
    Figure 12. Global Nucleic Acid Blood Screening Revenue Market Share by Type (2019-2024)
    Figure 13. Nucleic Acid Blood Screening Consumed in Blood Center
    Figure 14. Global Nucleic Acid Blood Screening Market: Blood Center (2019-2024) & (K Units)
    Figure 15. Nucleic Acid Blood Screening Consumed in Central Blood Station
    Figure 16. Global Nucleic Acid Blood Screening Market: Central Blood Station (2019-2024) & (K Units)
    Figure 17. Nucleic Acid Blood Screening Consumed in Central Blood Bank
    Figure 18. Global Nucleic Acid Blood Screening Market: Central Blood Bank (2019-2024) & (K Units)
    Figure 19. Global Nucleic Acid Blood Screening Sales Market Share by Application (2023)
    Figure 20. Global Nucleic Acid Blood Screening Revenue Market Share by Application in 2023
    Figure 21. Nucleic Acid Blood Screening Sales Market by Company in 2023 (K Units)
    Figure 22. Global Nucleic Acid Blood Screening Sales Market Share by Company in 2023
    Figure 23. Nucleic Acid Blood Screening Revenue Market by Company in 2023 ($ Million)
    Figure 24. Global Nucleic Acid Blood Screening Revenue Market Share by Company in 2023
    Figure 25. Global Nucleic Acid Blood Screening Sales Market Share by Geographic Region (2019-2024)
    Figure 26. Global Nucleic Acid Blood Screening Revenue Market Share by Geographic Region in 2023
    Figure 27. Americas Nucleic Acid Blood Screening Sales 2019-2024 (K Units)
    Figure 28. Americas Nucleic Acid Blood Screening Revenue 2019-2024 ($ Millions)
    Figure 29. APAC Nucleic Acid Blood Screening Sales 2019-2024 (K Units)
    Figure 30. APAC Nucleic Acid Blood Screening Revenue 2019-2024 ($ Millions)
    Figure 31. Europe Nucleic Acid Blood Screening Sales 2019-2024 (K Units)
    Figure 32. Europe Nucleic Acid Blood Screening Revenue 2019-2024 ($ Millions)
    Figure 33. Middle East & Africa Nucleic Acid Blood Screening Sales 2019-2024 (K Units)
    Figure 34. Middle East & Africa Nucleic Acid Blood Screening Revenue 2019-2024 ($ Millions)
    Figure 35. Americas Nucleic Acid Blood Screening Sales Market Share by Country in 2023
    Figure 36. Americas Nucleic Acid Blood Screening Revenue Market Share by Country in 2023
    Figure 37. Americas Nucleic Acid Blood Screening Sales Market Share by Type (2019-2024)
    Figure 38. Americas Nucleic Acid Blood Screening Sales Market Share by Application (2019-2024)
    Figure 39. United States Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 40. Canada Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 41. Mexico Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 42. Brazil Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 43. APAC Nucleic Acid Blood Screening Sales Market Share by Region in 2023
    Figure 44. APAC Nucleic Acid Blood Screening Revenue Market Share by Regions in 2023
    Figure 45. APAC Nucleic Acid Blood Screening Sales Market Share by Type (2019-2024)
    Figure 46. APAC Nucleic Acid Blood Screening Sales Market Share by Application (2019-2024)
    Figure 47. China Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 48. Japan Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 49. South Korea Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 50. Southeast Asia Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 51. India Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 52. Australia Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 53. China Taiwan Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 54. Europe Nucleic Acid Blood Screening Sales Market Share by Country in 2023
    Figure 55. Europe Nucleic Acid Blood Screening Revenue Market Share by Country in 2023
    Figure 56. Europe Nucleic Acid Blood Screening Sales Market Share by Type (2019-2024)
    Figure 57. Europe Nucleic Acid Blood Screening Sales Market Share by Application (2019-2024)
    Figure 58. Germany Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 59. France Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 60. UK Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 61. Italy Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 62. Russia Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 63. Middle East & Africa Nucleic Acid Blood Screening Sales Market Share by Country in 2023
    Figure 64. Middle East & Africa Nucleic Acid Blood Screening Revenue Market Share by Country in 2023
    Figure 65. Middle East & Africa Nucleic Acid Blood Screening Sales Market Share by Type (2019-2024)
    Figure 66. Middle East & Africa Nucleic Acid Blood Screening Sales Market Share by Application (2019-2024)
    Figure 67. Egypt Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 68. South Africa Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 69. Israel Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 70. Turkey Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 71. GCC Country Nucleic Acid Blood Screening Revenue Growth 2019-2024 ($ Millions)
    Figure 72. Manufacturing Cost Structure Analysis of Nucleic Acid Blood Screening in 2023
    Figure 73. Manufacturing Process Analysis of Nucleic Acid Blood Screening
    Figure 74. Industry Chain Structure of Nucleic Acid Blood Screening
    Figure 75. Channels of Distribution
    Figure 76. Global Nucleic Acid Blood Screening Sales Market Forecast by Region (2025-2030)
    Figure 77. Global Nucleic Acid Blood Screening Revenue Market Share Forecast by Region (2025-2030)
    Figure 78. Global Nucleic Acid Blood Screening Sales Market Share Forecast by Type (2025-2030)
    Figure 79. Global Nucleic Acid Blood Screening Revenue Market Share Forecast by Type (2025-2030)
    Figure 80. Global Nucleic Acid Blood Screening Sales Market Share Forecast by Application (2025-2030)
    Figure 81. Global Nucleic Acid Blood Screening Revenue Market Share Forecast by Application (2025-2030)

Companies Mentioned

Roche

Grifols Diagnostic Solutions

PerkinElmer

KHB

Bacme Bio

Daan Gene

Wantai Biotechnology

Sansure Biotech

Zhuhai Livzon Reagents

Bio-Rad Laboratories

Horiba

Thermo Fisher Scientific

bioMerieux

Danaher

Abbott

Mindray

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff